Recombinant retroviral vectors represent an attractive means of transferring genes into the liver because they integrate in the host cell genome and result in permanent gene expression. However, efficient gene transfer is limited by the requirement of active cell division for integration. Surgical partial hepatectomy has been the traditional method of inducing hepatocellular proliferation, but this invasive approach would be difllcult to justify in clinical gene therapy. As an alternative, we used a recombinant adenovirus expressing a nonsecreted form of urokinase plaminogen activator (Ad.PGKmuPA), which results in liver regeneration over a period of 8 days. When a high-titer retroviral vector was continuously infused into the portal vein of mice during this period of hepatocyte proliferation, 33.5% of hepatocytes were stably transduced. In addition, high-level expression of a secreted transgene reporter was sustained for at least 48 weeks (length of experiment). We investigated the influence of vector titer on the in vivo transduction efficiency in our system, and found that the total number of infectious retroviral particles delivered per target cell is a critical factor. The results presented here demonstrate the ability to obtain a high gene transfer efficiency and long-term gene expression in hepatocytes in vivo without the need for surgical hepatectomy. The two-vector system described here may be of clinical relevance, as the level of hepatic gene transfer achieved has potential to be curative for a large number of genetic liver diseases.
INTRODUCTION
THE LIVER REPJLESENTS an important target organ for gene therapy since many genetic liver diseases result from the deficiency of liver-specific gene products. The use of recombinant retroviral vectors is attractive for this purpose because of transgene integration into the host genome and long-term stable gene expression (Ferry et al, 1991; Kaleko et al, 1991; Kay era/., 1992 Kay era/., ,1993 Rozga era/., 1992; Kolodka ef a/., 1993; Rettinger et al, 1994) . In addition, retroviral vectors do not 'Markey Molecular Medicine Center, Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, WA 98195. ^Departments of Biochemistry, Pathology, and Pediatrics, University ofWashington, Seattie, WA 98195. elicit a cytotoxic cellular immune response because no viral genes are contained in the vector.
An important limitation to efficient gene transfer using retroviral vectors has been the requirement for active proliferation of target cells (Miller et al, 1990) . Under physiological conditions most mature hepatocytes are quiescent (Fausto and Webber, 1994) . The conventional strategy to induce hepatocellular proliferation for in vivo gene transfer was to perform a surgical 70% partial hepatectomy (Ferry et al, 1991; Kay et al, 1992; Kolodka et al, 1993; Rettinger et al, 1994) , but this approach was traumatic, and technically difficult in humans, and may not be clinically acceptable. Other approaches reported to induce liver proliferation for this purpose include portal branch ligation (Rozga et al, 1992; Bowling et al, 1996) or the infusion of growth factors (Bosch et al, 1996; Patijn et al, 1998a) . As a noninvasive altemative to partial hepatectomy, a new method to induce liver regeneration was previously developed in our laboratory, involving the use of a recombinant adenovirus that ttansientiy expresses a modified (nonsecreted) urokinasetype plasminogen activator: Ad.PGKmuPA (Lieber et al, 1995b,c) . The inttacellular expression of muPA is toxic only to hepatocytes and results in asynchronous hepatocyte tumover beginning within the first days after gene transfer, followed by liver regeneration over a period of about 8 days, with complete normalization of the liver by 3 weeks. In a previous study using Ad.PGKmuPA in mice, three retrovirus infusions of 1 ml on days 3, 5, and 7 after adenovirus administration resulted in an average gene transfer of 1% of hepatocytes (Lieber et al, 1995c) .
Since murine leukemia virus (MuLV)-derived retroviral vectors lose their ability to integrate after infection, with a halflife of 5.5-7.5 hr (Andreadis et al, 1997) , it is important to synchronize hepatocyte replication and vector delivery (Branchereau et al, 1994) . We hypothesized that optimal gene transfer efficiency using Ad.PGKmuPA would be achieved when retrovirus is continuously supplied to the liver during liver regeneration. For this purpose we developed a continuous infusion system into the portal vein of mice. Because retroviral titers have been reported to be critical for efficient in vivo gene transfer (Bowles et al, 1996; Kitten et al, 1997) , we investigated the influence of retroviral titer on transduction efficiency in our two-vector system. sion system are described elsewhere (Patijn et al, 1998b) . Briefly, the distal end of the cannula was tunneled subcutanously from the abdominal exit site to the posterior scapular region, exteriorated, and connected to a syringe, which was mounted on a multiple syringe pump (Harvard Apparatus, South Natick, MA). To maintain cannula patency, a slow infusion of sterile saline was started after portal vein cannulation at 0.1 ml/hr. To protect the cannula at the exit site, a mouse tether assembly was attached (Instech Laboratories, Plymouth Meeting, PA). After completion of the retrovirus infusion, the mice were disconnected from the infusion system and the tether was removed under general anesthesia.
Recombinant adenovirus
The endotoxin-negative (Lieber et al, 1997) and replication competent retrovirus (RCA)-negative (<1 X 10*/10' plaqueforming units [PFU] ) (Barr et al, 1995) recombinant first-generation adenoviral vector Ad.PGKmuPA (Lieber et al, 1995b) , or the irrelevant control adenovirus Ad.RSVhAAT , with viral titers ranging from 1 X 10" to 2.3 X 10" PFU/ml (as detennined by plaque assay on 293 cells), was diluted in sterile saline to a 200-/xl final volume before infusion.
Recombinant retrovirus
The amphotropic retrovirus produced from TELCeB6 AF7 (Cosset et al, 1995) (referted to as AF7) encoding the nuclearlocalized Escherichia coli ^-galactosidase gene had an average titer of 0.5 X 10* colony-forming units (CFU)/ml (as determined on 208F cells). The absence of helper virus in vector preparations was reconfirmed (Cosset et al, 1995) . The rettoviral vectors LBgeo, encoding the E. coli /3-galactosidase gene, and LNAlbhAAT, encoding the human apantitrypsin gene, were previously described (Kay et al, 1992) and had titers of 1.5 X 10« and 1 X 10* CFU/ml, respectively. All three recombinant retroviruses were based on the amphottopic murine leukemia virus and had similar structures using the MuLV long tenninal repeats (LTRs) to drive the transgene. To ensure a relatively constant retroviral titer during infusion, a new batch of retrovirus was collected every 8 hr, altemating two sets of tissue culture plates. On collection and filtration, Polybrene (12 pgJmX; Sigma, St. Louis, MO) was added and vector was ttansfened into a separate syringe for each mouse.
MATERIALS AND METHODS

Animals
All animal studies were performed in accordance with the NIH Guidelines for Animal Care and Use and with the institutional guidelines of the University of Washington (Seattle, WA). Female C57BL6 mice, 5-6 weeks old were purchased from Taconic Laboratory (Germantown, NY) and housed in a specific pathogen-free (SPF) environment.
Surgical procedures
The portal vein cannulation was perfonned as described (Vrancken-Peeters et al, 1996) ; details of the continuous infu-
Experimental protocols
Animals were cannulated on day -1 and Ad.PGKmuPA (5 X 10' PFU total), control adenovirus Ad.RSVhAAT (5 X 10' PFU total), or saline was administered via the portal vein cannula on day 0. After adenovirus administration, slow infusion of nonnal saline was continued. Rettovirus AF7 or LBgeo was then continuously infused on days 3-7 at a rate of 0.25 ml/hr, as liver regeneration starts on day 3 and peaks on days 4-7 after Ad.PGKmuPA administration (Lieber et al, 1995b) . As an additional control, the transduction rate was compared with that in animals who underwent a 70% partial hepatectomy (Kay et al, 1992) , Because hepatocellular DNA replication in hepatectomized C57BL/6 mice peaks at about 40 hr postoperatively (Yamada et al, 1997), they were infused with rettovinis starting on day 1 (versus day 3), and continuing through day 5 (versus day 7), with each mouse receiving tiie same amount of reti-ovirus as Ad.PGKmuPA-tteated mice. In a separate experiment using the same protocol, rettovirus LNAlbhAAT was infused after Ad.PGKmuPA to test for persistence of expression.
The total amounts of rettovirus particles administered over the 5 days were 1.5 X 10' CFU (AF7) and 3 X 10^ CFU (LBgeo). Assuming the normal adult mouse liver has 10* cells, the total multiplicity of infection (MOI) was 15 and 0.3 respectively.
Tissue analysis
Rettovirus-infused animals were sacrificed on day 28 after the beginning of infusion. To detect j8-galactosidase (/3-Gal) activity, liver tissue was embedded in O.C.T. (Miles, Elkhart, IL) snap frozen in methylbutane, and 10-/Lim sections were fixed with 1.25% glutaraldehyde and stained ovemight with 5-bromo-4-chloro-3-indolyl-/3-D-galactopyranoside (X-Gal; Sigma). The proportion of X-Gal-positive nuclei was determined by counting at least 300 cells per X200 field from at least 8 random fields. For routine histology, liver samples were fixed in formalin (10%, v/v), embedded in paraffin, and stained with hematoxylin-eosin.
RESULTS
Ad.PGKmuPA and continuous retrovirus infusion allow for highly efficient and persistent gene transfer into hepatocytes in vivo Four weeks after infusion, the livers were analyzed for the relative number of /3-Gal-positive cells by X-Gal histochemistry (Table 1, Fig. 1 ). After injection of Ad.PGKmuPA, on average, 33.5% (AF7) and 11.5% (LBgeo) of hepatocytes were /3-Gal positive, whereas mice that received conttol adenovirus or saline had <1% j8-Gal-positive cells. Partial hepatectomized mice had 11.3% (AF7) and 2.3% (LBgeo) /3-Gal-positive hepatocytes. All cells staining blue had characteristic hepatocyte morphology. There was no preferential localization of transduced cells in each liver section that was examined and only rare nonparenchymal /3-Gal-positive cells were detected. Notably, Ad.PGKmuPA-treated mice showed both single transduced cells and clustered populations of up to four to eight blue cells (Fig. II) . These results suggest that at least two or three cell divisions occuned in ttansduced hepatocytes. Extrahepatic tissues, including kidney, heart, lung, intestine, spleen, brain, skeletal muscle, skin, and gonads, did not stain after X-Gal histochemistry (not shown).
To evaluate for the persistence of transgene expression, serum hAAT concentrations were measured over time after infusion with rettovirus LNAlbhAAT (total MOI of 0.45) (Fig.  2) . In Ad.PGKmuPA-treated mice, serum human ai-antitrypsin (hAAT) concenttations ranged from 953 to 2510 ng/ml, and this range persisted for at least 48 weeks (length of study). On average this was sixfold higher than that achieved with three 1-ral bolus administtations of tiie same retrovuns after Ad.PGKmuPA administration in our previous study (Lieber et al, 1995c) .
Safety of Ad.PGKmuPA and continuous retrovirus administration
Throughout the infusion, the Ad.PGKmuPA-tteated mice appeared healthy despite the hepatocellular injury, the attached tether, and retrovirus infusion. At 4 weeks, routine histological evaluation was performed on livers from experimental and control mice (not shown). No abnormalities were found, which demonstrates, as we have previously shown (Lieber et al, 1995c) , that the regeneration was complete, retaining normal hepatic macro-and microarchitecture. Livers of control mice that did not receive adenovirus were histologically normal at the end of the 5-day retrovirus infusion, indicating that the relatively large volume of retrovirus infusion had no adverse effects.
The surgical procedure and infusion were associated with low mortality (<3%), which was related to air emboli and occuned only within 24 hr after surgery. In contrast, when mice were continuously infused after partial hepatectomy, mortality was significant (70%). This was likely due to the combined reduction in liver function and portal hypertension, as the portal vascular resistance was significantly increased after removal of Table 1 ''After injection of Ad.PGKmuPA on day 0, C57BL/6 mice were continuously infused with recombinant rettoviruses expressing /3-Gal on days 3-7 at 0.25 ml/hr. Control mice underwent partial hepatectomy or received an urelevant control adenovirus or saline before rettovirus infusion. Mice were sacrificed on day 28 and frozen liver sections were stained with X-Gal. The proportion (percentage) of hepatocyte nuclei staining blue was determined by counting at least 300 cells per X200 field from at least 8 random fields. Values represent means and standard deviation (n > 3).
"p < 0.005 (comparing the MOI 15 group with tiie MOI 0.3 group) as determined by Student's t test. 
DISCUSSION
In this study, we demonstrate that highly efficient retroviral gene ttansfer (33.5%) into the livers of mice can be achieved using Ad.PGKmuPA and high-titer retrovirus without the need for surgical hepatectomy. The results indicate that continuous vector administration may be an important factor in enhancing gene transfer efficiency in our model, which is related to a higher total MOI during a period of continued hepatic regeneration (Branchereau et al, 1994) . In a previous study from our laboratory, mice received three 1-ml injections of low-titer rettovirus LBgeo (total MOI of 0.03) on days 3, 5, and 7 after administration of Ad.PGKmuPA, resulting in average transduction of 7% of hepatocytes (Lieber et al, 1995c) . By continuous administration of the same vector, the MOI of the vector transfused was increased by 10-fold (total MOI of 0.3 versus 0.03), but resulted in a 1.6-fold increase in the number of transduced cells. Continuous infusion of hightiter retrovirus AF7 increased the MOI 50-fold (total MOI of 15 versus 0.3), and resulted in an additional 3-fold relative increase in transduced cells. These results, which were all based on X-Gal staining, show a nonproportional increase in in vivo retrovirus-mediated gene transfer with increasing MOI. This finding is consistent with reports by others using partial hepatectomy to induce regeneration (Bowles et al, 1996; Kitten et al, 1997) .
In our system the gene transfer efficiency was 33.5% with a total MOI of 15 administered over 5 days. However, owing to the gradual process of hepatocyte tumover and regeneration after administration of Ad.PGKmuPA, only a small portion of hepatocytes are replicating at a single point in time. Thus, it is likely that only a relatively small proportion of the infused vector particles actually infect dividing cells. Since MuLV-based retroviral vectors are unstable at 37°C and quickly lose their ability to integrate (Andreadis et al, 1997) , a significant number of particles would therefore be lost for transduction in our model. As a result, even though we have shown that the relative gain of transduction with higher MOI was not proportional, the gene transfer efficiency could potentially be further improved with higher MOIs.
After infusion of control adenovirus, a low number of transduced cells was found, indicating that a low level of DNA replication occuned in the livers of these mice. This is most likely due to low-grade hepatocellular injury by adenovirus toxicity, or by innate and noninnate immune mechanisms (Ban et al, 1995; Lieber et al, 1996 Lieber et al, , 1997 Wolff et al, 1997; . The infusion by itself did not induce significant DNA replication, since retrovirus infusion in mice pretreated with saline alone did not result in gene transfer.
In our hands, high-titer retrovirus-mediated gene transfer after partial hepatectomy (11.3%) was three times lower than after Ad.PGKmuPA administration (33.5%). These results are in contrast to a study in rats that showed 46% transduced hepatocytes after partial hepatectomy (Kitten et al, 1997) . In that study, a high-titer retrovirus was administered in two bolus injections into the portal vein around the peak of DNA synthesis after partial hepatectomy. The total MOI was 2, whereas we continuously infused rettovirus over a 5-day period up to a total MOI of 15. However, because of the synchronous nature and short duration of DNA replication after partial hepatectomy, rettovirus delivery is effective only during a 12-hr period around the peak of cell division. During this critical period, we PGKmuPA, C57BL/6 mice were infused with the LNAlbhAAT rettovirus. Serum human ai-antitrypsin (hAAT) concentrations were measured periodically by ELISA as described (Kay et al, 1992) . Each sample was analyzed in duplicate. Each line represents an individual animal. infused a total MOI of no more than 1.5, which may in part explain the lower gene transfer efficiency that was observed after partial hepatectomy. In addition, for reasons unknown, retrovirus-mediated gene transfer into the liver has generally been higher in rats than in other species (Kay et al, 1992 Kolodka et al, 1993; Branchereau et al, 1994) .
Clearly, the number of infused retroviral particles per hepatocyte (MOI) is a critical factor for improved hepatic gene transfer in vivo. However, the relative gain in gene transfer efficiency decreases with higher MOIs. Besides the kinetics of vector delivery and cell division, there will likely be additional factors that influence the transduction efficiency, including circulating neutralizing antibodies to retroviral proteins in certain mouse strains (Fassati etal, 1995) , availability of receptor (Kavanaugh et al, 1994) , secreted inhibitory proteins (Miller and Miller, 1993) , and transcriptional silencing after proviral integration (Fincham and Wyke, 1991; Hoeben et al, 1991; Kay et al, 1992) . Suboptimal dynamics of vector perfusion into different portions of the liver is not likely to preclude higher efficiencies in our model, because we found similar numbers of transduced cells in all three functional zones throughout the liver. Further studies are needed to disclose and understand all factors involved. Only then may the full potential of in vivo gene transfer with retroviral vectors eventually be achieved.
Although the infusions were safe and well tolerated, we infused a relatively high volume in order to deliver the highest possible number of vector particles. The production of packaging cell lines that yield higher titers and improved methods for retrovirus concentration will obviate the need for such highvolume infusion. In patients, short-term access to the portal circulation may be obtained safely using minimally invasive techniques.
The study here demonstrates that when using Ad.PGKmuPA to induce liver regeneration, a high transduction efficiency, and sustained gene expression without the need for surgical hepatectomy. When using high-titer retroviral vectors carrying genes encoding therapeutic proteins, curative levels of systemic gene expression for a large number of genetic liver diseases, including hemophilia, may be achieved. With additional safety features such as viral gene-deleted adenoviral vectors, and inducible liver-specific promotors, to allow more precise titration and control of hepatocellular regeneration, an approach such as the two-vector system described here may allow for permanent gene expression in clinical hepatic gene therapy.
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